Skip to content

Feed Screener MCP Methodology

⌘K

EN

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
AMF · FR
BAFIN · DE

Product

Ask the record
Help
Methodology
Signal backtests
Terms
Privacy notice
Object to processing

Language

English Español Français

Feed Screener MCP Methodology

English Español Français

Pricing Sign in

Chin Peter Scott — Denali Therapeutics Inc. insider: 1 transactions · InsiderLens

/ / Chin Peter Scott

Chin Peter Scott

Chief Medical Officer at Denali Therapeutics Inc. · on record since Apr 20, 2026

Insider trading activity of Chin Peter Scott

Transactions on record: 1; since Sep 9, 2026

Open-market buys: 0

Open-market sells: 1; $36.9K

Companies traded: 1; last filing Sep 9, 2026

Figures computed from official regulatory filings — .

Companies where Chin Peter Scott has traded

Denali Therapeutics Inc.1 tx · $36.9K · Sep 9, 2026

Track record of Chin Peter Scott

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Chin Peter Scott

Co-insiders of Chin Peter Scott

667, L.P.Denali Therapeutics Inc.
AFEYAN NOUBARDenali Therapeutics Inc.
AKDL, L.P.Denali Therapeutics Inc.
ARCH Venture Fund VIII, L.P.Denali Therapeutics Inc.
ARCH Venture Partners VIII, LLCDenali Therapeutics Inc.
ARCH Venture Partners VIII, L.P.Denali Therapeutics Inc.
Baker Bros. Advisors (GP) LLCDenali Therapeutics Inc.
BAKER BROS. ADVISORS LPDenali Therapeutics Inc.
Baker Brothers Life Sciences LPDenali Therapeutics Inc.
BAKER FELIXDenali Therapeutics Inc.
BAKER JULIANDenali Therapeutics Inc.
BIOGEN IDEC INCDenali Therapeutics Inc.
Biogen MA Inc.Denali Therapeutics Inc.
Bratton Capital Inc.Denali Therapeutics Inc.
Bratton Capital Management, L.P.Denali Therapeutics Inc.
BRATTON DOUGLAS KDenali Therapeutics Inc.
BYBEE CLINTONDenali Therapeutics Inc.
Cole Douglas G.Denali Therapeutics Inc.
Cook Jennifer E.Denali Therapeutics Inc.
CRANDELL KEITHDenali Therapeutics Inc.
Crestline Investors, Inc.Denali Therapeutics Inc.
Crestline Management, LPDenali Therapeutics Inc.
Crestline SI (GP), L.P.Denali Therapeutics Inc.
FIL LtdDenali Therapeutics Inc.
Flagship Ventures Fund V General Partner LLCDenali Therapeutics Inc.
Flagship Ventures Fund V, L.P.Denali Therapeutics Inc.
FLATLEY JAY TDenali Therapeutics Inc.
FMR LLCDenali Therapeutics Inc.
Harris ErikDenali Therapeutics Inc.
Ho CaroleDenali Therapeutics Inc.
Klein Peter SDenali Therapeutics Inc.
Krognes Steve E.Denali Therapeutics Inc.

This page republishes public regulatory disclosures.

NELSEN ROBERTDenali Therapeutics Inc.

Neuro Line Partners LPDenali Therapeutics Inc.

SATO VICKI LDenali Therapeutics Inc.

Schenkein David PDenali Therapeutics Inc.

Schuth Alexander O.Denali Therapeutics Inc.

Tessier-Lavigne MarcDenali Therapeutics Inc.

Thornberry NancyDenali Therapeutics Inc.

Van Hauwermeiren TimothyDenali Therapeutics Inc.

Watts Ryan J.Denali Therapeutics Inc.

Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src	Details
Denali Therapeutics Inc.Listing on record	Sep 9, 2026	Sell	-1,654	22.29 USD	$36.9K		SEC